Akorn Inc $34.48

down 0.00


22/7/2014 04:00 PM  |  NASDAQ : AKRX  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get AKRX Trend Analysis - it has outperformed the S&P 500 by 137%

Partner Headlines

  1. Market Loses Its Swagger In Afternoon Trade

    IBD
  2. Stocks Recover From Early Fade; Whiting Hits New High

    IBD
  3. Stocks Recover Impressively; Gap Slumps In After Hours

    IBD
  4. Stocks Claw Way Back After Morning Sell-Off

    IBD
  5. Stocks Add To Losses; TAL Education Bucks Weakness

    IBD
  6. Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week

    IBD
  7. Pharmas Soar To New Highs

    IBD
  8. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD
  9. S&P 500, Dow At New Highs; 14-Year High For Nasdaq

    IBD
  10. Stocks Rise In Strong Turnover; Netflix Soars On Upgrade

    IBD
  11. Akorn Shares Rally Following Increased Price Target

    Benzinga
  12. Stocks Add To Gains; Salix, Akorn Ramp Higher

    IBD
  13. Benzinga's Volume Movers

    Benzinga
  14. Stocks Mixed In Late Trade, But Growth Stocks Outperform

    IBD
  15. Nasdaq Showing Outperformance; GoPro Extends Gains

    IBD
  16. Stocks Hitting 52-Week Highs

    Benzinga
  17. Stocks Give Up Gains; Volume Picks Up

    IBD
  18. Indexes Mixed As Stocks Pare Earlier Gains

    IBD
  19. Akorn

    IBD
  20. Growth Stocks Kick Into Gear In Latest IBD 50 Screen

    IBD
  21. Akorn Shares Gaining On $41 Million Sale Of Branded Drugs Unit To Valeant

    Benzinga
  22. Stocks Fall Modestly; Lufthansa Warning Nails Airlines

    IBD
  23. Several IBD 50 Names Set Up In Stock Picker's Market

    IBD
  24. Lannett Tops Trio Of Medical Small Cap Leaders

    IBD
  25. UPDATE: Bank Of America Reiterates On Akorn As Diverse Niche Player

    Benzinga
  26. Stocks End Mixed; S&P 500 Marks All-Time Closing High

    IBD
  27. Merck Sells Japan Eye-Treatment Rights

    FoxBusiness
  28. Top 4 Mid-Cap Stocks In The Drugs-Generic Industry With The Highest ROA

    Benzinga
  29. Benzinga's Weekend M&A Chatter

    Benzinga
  30. Akorn Acquires VersaPharm

    IBD
  31. IBD 50 High-Growth Shares Remain In Correction

    IBD
  32. Stocks Close Higher After Late Boost; Air Lease Gains

    IBD
  33. Stocks Go From Red To Green; Akorn Up On Acquisition

    IBD
  34. Akorn Buying VersaPharm To Beef Up Topical Offerings

    IBD
  35. UPDATE: Akorn Acquires VersaPharm For $440M

    Benzinga
  36. Akorn

    IBD
  37. Akorn Q1 EPS Beats, Raises Full-Year Profit Outlook

    IBD
  38. Most-Recent Breakouts Among IBD 50 Stocks Mixed So Far

    IBD
  39. Akorn's guidance disappoints

    IBD
  40. Akorn Guidance Worries Street As Strategy Hits Delays

    IBD
  41. Stocks Down Hard But Up Slightly From Session Lows

    IBD
  42. Mid-Day Market Update: Akorn Shares Slip After Downbeat Outlook; Dendreon ...

    Benzinga
  43. Morning Losers for Mar. 3, 2014: YNDX, CETV, AKRX, CPST, LIVE

    Benzinga
  44. Stocks Edge Lower, Trade Mixed; Oil, Bonds, Dollar Rising

    IBD
  45. Mid-Morning Market Update: Markets Open Lower; Tyco To Sell South Korean ...

    Benzinga
  46. Morning Market Losers

    Benzinga
  47. Akorn Q4 Meets But Guidance Disappoints, Stock Down

    IBD
  48. Earnings Scheduled For March 3, 2014

    Benzinga
  49. Qihoo, WuXi, Akorn Among Last IBD 50 Earnings Reports

    IBD
  50. 2 Weak Breakouts, A Few Sell-Offs For The IBD 50

    IBD
Trading Center